IDEXX Laboratories, Inc. (IDXX)
NASDAQ$419.52
Market Cap
$34.12B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
635 of 924
Rank in Industry
31 of 49
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
IDXX Insider Trading Activity
IDXX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $6,504,172 | 5 | 100 |
Related Transactions
| Claflin Bruce L. | director | 0 | $0 | 1 | $108,160 | $-108,160 |
| Vandebroek Sophie V. | director | 0 | $0 | 1 | $144,630 | $-144,630 |
| SZOSTAK M ANNE | director | 0 | $0 | 2 | $1.63M | $-1.63M |
| FENNELL GEORGE | Executive Vice President | 0 | $0 | 1 | $4.62M | $-4.62M |
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for …
Insider Activity of IDEXX Laboratories, Inc.
Over the last 12 months, insiders at IDEXX Laboratories, Inc. have bought $0 and sold $6.5M worth of IDEXX Laboratories, Inc. stock.
On average, over the past 5 years, insiders at IDEXX Laboratories, Inc. have bought $0 and sold $82.91M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 750 shares for transaction amount of $199,808 was made by Kingsley Lawrence D (director) on 2019‑08‑06.
List of Insider Buy and Sell Transactions, IDEXX Laboratories, Inc.
| 2025-02-10 | Sale | FENNELL GEORGE | Executive Vice President | 9,986 0.0123% | $462.53 | $4.62M | -5.14% | |
| 2025-02-07 | Sale | SZOSTAK M ANNE | director | 3,000 0.0037% | $465.94 | $1.4M | -4.01% | |
| 2024-11-27 | Sale | Vandebroek Sophie V. | director | 344 0.0004% | $420.44 | $144,630 | +2.07% | |
| 2024-09-06 | Sale | SZOSTAK M ANNE | director | 500 0.0006% | $469.37 | $234,686 | -7.59% | |
| 2024-05-17 | Sale | Claflin Bruce L. | director | 200 0.0002% | $540.80 | $108,160 | -14.05% | |
| 2024-03-06 | Sale | POLEWACZYK JAMES F | Executive Vice President | 8,104 0.0098% | $558.44 | $4.53M | -14.50% | |
| 2024-03-05 | Sale | Vandebroek Sophie V. | director | 1,404 0.0017% | $562.98 | $790,427 | -14.56% | |
| 2024-02-08 | Sale | FENNELL GEORGE | SVP, Chief Revenue Officer | 8,198 0.0109% | $573.87 | $4.7M | -15.78% | |
| 2024-02-07 | Sale | MAZELSKY JONATHAN JAY | President and CEO | 12,000 0.0159% | $572.61 | $6.87M | -15.54% | |
| 2024-02-07 | Sale | MCKEON BRIAN P | EVP, CFO and Treasurer | 23,326 0.0307% | $570.01 | $13.3M | -15.54% | |
| 2023-12-07 | Sale | POLEWACZYK JAMES F | Executive Vice President | 11,636 0.014% | $521.79 | $6.07M | -4.98% | |
| 2023-12-04 | Sale | MAZELSKY JONATHAN JAY | President and CEO | 7,128 0.0085% | $513.05 | $3.66M | -3.65% | |
| 2023-08-31 | Sale | MAZELSKY JONATHAN JAY | President and CEO | 13,424 0.0162% | $512.01 | $6.87M | -3.21% | |
| 2023-08-29 | Sale | POLEWACZYK JAMES F | Executive Vice President | 22,909 0.0276% | $510.56 | $11.7M | -3.07% | |
| 2023-08-15 | Sale | AYERS JONATHAN W | director | 492 – | $0 | $0 | -2.63% | |
| 2023-08-03 | Sale | Lane Michael | Executive Vice President | 16,027 0.0194% | $510.00 | $8.17M | -1.62% | |
| 2023-05-19 | Sale | AYERS JONATHAN W | director | 10,000 0.0121% | $491.35 | $4.91M | +3.17% | |
| 2023-05-18 | Sale | AYERS JONATHAN W | director | 10,000 0.012% | $489.23 | $4.89M | +2.24% | |
| 2023-05-05 | Sale | SZOSTAK M ANNE | director | 2,000 0.0023% | $474.89 | $949,789 | +2.08% | |
| 2023-05-05 | Sale | Lane Michael | Executive Vice President | 1,000 0.0012% | $484.00 | $484,000 | +2.08% |
Total: 477
*Gray background shows transactions not older than one year
Insider Historical Profitability
16.2%
| SZOSTAK M ANNE | director | 3061 0.0038% | $1.28M | 4 | 10 | +20.21% |
| Vandebroek Sophie V. | director | 905 0.0011% | $379,665.60 | 1 | 7 | +18.18% |
| Claflin Bruce L. | director | 161 0.0002% | $67,542.72 | 2 | 4 | +4.5% |
| AYERS JONATHAN W | director | 135547 0.1667% | $56.86M | 1 | 124 | +36.54% |
| MCKEON BRIAN P | EVP, CFO and Treasurer | 29718 0.0365% | $12.47M | 1 | 18 |
*Gray background shows insiders who have made transactions during last year
IDXX Institutional Investors: Active Positions
| Increased Positions | 501 | +36.62% | 8M | +10.36% |
| Decreased Positions | 592 | -43.27% | 9M | -12.68% |
| New Positions | 160 | New | 2M | New |
| Sold Out Positions | 151 | Sold Out | 583,504 | Sold Out |
| Total Postitions | 1,277 | -6.65% | 72M | -2.31% |
IDXX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $4.03M | 11.99% | 9.71M | +6,257 | +0.06% | 2024-12-31 |
| Blackrock, Inc. | $3.52M | 10.46% | 8.47M | -942,652 | -10.01% | 2024-12-31 |
| State Street Corp | $1.51M | 4.49% | 3.64M | +24,200 | +0.67% | 2024-12-31 |
| Fundsmith Llp | $1.11M | 3.29% | 2.66M | -1,307 | -0.05% | 2024-12-31 |
| Geode Capital Management, Llc | $954,057.00 | 2.84% | 2.3M | +37,734 | +1.67% | 2024-12-31 |
| Bamco Inc /Ny/ | $832,893.00 | 2.48% | 2.01M | +82,264 | +4.28% | 2024-12-31 |
| Morgan Stanley | $678,201.00 | 2.02% | 1.63M | +451,330 | +38.19% | 2024-12-31 |
| Alliancebernstein L.P. | $514,648.00 | 1.53% | 1.24M | -2M | -56.02% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $482,972.00 | 1.44% | 1.16M | -373,905 | -24.33% | 2024-12-31 |
| Invesco Ltd. | $482,158.00 | 1.43% | 1.16M | +74,324 | +6.84% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.